A Look At Twist Bioscience (TWST) Valuation After A Strong Multi Year Share Price Run

Simply Wall St.06-03

AdvertisementRecent performance snapshot Twist Bioscience (TWST) has drawn fresh attention in early June as investors reassess the stock after a strong year to date move. The share price last closed ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2640894747?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","is_english":true,"pubTime":"2026-06-03 01:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2640894747","market":"nz","top_or_hot":-1,"title":"A Look At Twist Bioscience (TWST) Valuation After A Strong Multi Year Share Price Run","media":"Simply Wall St.","content":"<div>\n<p>AdvertisementRecent performance snapshot Twist Bioscience (TWST) has drawn fresh attention in early June as investors reassess the stock after a strong year to date move. The share price last closed ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-twst/twist-bioscience/news/a-look-at-twist-bioscience-twst-valuation-after-a-strong-mul\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>A Look At Twist Bioscience (TWST) Valuation After A Strong Multi Year Share Price Run</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nA Look At Twist Bioscience (TWST) Valuation After A Strong Multi Year Share Price Run\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-06-03 01:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-twst/twist-bioscience/news/a-look-at-twist-bioscience-twst-valuation-after-a-strong-mul><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>AdvertisementRecent performance snapshot Twist Bioscience (TWST) has drawn fresh attention in early June as investors reassess the stock after a strong year to date move. The share price last closed ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-twst/twist-bioscience/news/a-look-at-twist-bioscience-twst-valuation-after-a-strong-mul\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4588","symbol_name":"碎股","start_time":0,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-twst/twist-bioscience/news/a-look-at-twist-bioscience-twst-valuation-after-a-strong-mul","article_id":"2640894747","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-twst/twist-bioscience/news/a-look-at-twist-bioscience-twst-valuation-after-a-strong-mul","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2640894747","pubTimestamp":1780421086,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Recent performance snapshot\nTwist Bioscience (TWST) has drawn fresh attention in early June as investors reassess the stock after a strong year to date move. The share price last closed at $67.86.\nThe company now carries a market value of about $4.16b, with reported annual revenue of $409.479 million and a net loss of $81.276 million. This is setting the stage for closer scrutiny of its growth profile and risks.\nSee our latest analysis for Twist Bioscience.\nBeyond the latest move, Twist...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4588":"碎股","TWST":"Twist Bioscience Corp","BK4139":"生物科技","BK4585":"ETF&股票定投概念"},"translate_title":"Twist Bioscience(TWST)股价多年强劲上涨后的估值","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TWST":1.5},"content_text":"AdvertisementRecent performance snapshot Twist Bioscience (TWST) has drawn fresh attention in early June as investors reassess the stock after a strong year to date move. The share price last closed at $67.86. The company now carries a market value of about $4.16b, with reported annual revenue of $409.479 million and a net loss of $81.276 million. This is setting the stage for closer scrutiny of its growth profile and risks. See our latest analysis for Twist Bioscience. Beyond the latest move, Twist Bioscience has been on a strong run, with a year-to-date share price return of 109.51% and a 1-year total shareholder return of 118.45%. This points to strong momentum supported by a very large 3-year total shareholder return of 319.15%, even though the 5-year total shareholder return has declined 33.32%. If you are looking for other fast-changing opportunities in related areas like biotech tools and data-driven therapeutics, it could be worth scanning 40 healthcare AI stocks With the stock up sharply over the past year, trading slightly above the average analyst price target of US$64.44, you now need to ask: is Twist Bioscience undervalued, or is the market already pricing in future growth? Most Popular Narrative: 7.1% Overvalued With Twist Bioscience last closing at $67.86 against a widely followed fair value estimate of about $63.33, the most popular narrative sees the stock trading ahead of that modeled level and leans heavily on long term earnings potential to justify its stance.  Significant improvements in gross margin (now above 50%) through volume leverage, process improvements, and increased vertical integration signal ongoing margin expansion and a clear near-term path toward adjusted EBITDA breakeven, indicating robust future earnings potential.  Read the complete narrative. Want to see what sits behind that confidence in future earnings power? The narrative leans on steady revenue expansion, rising margins and a rich future earnings multiple that is usually reserved for market favorites. Result: Fair Value of $63.33 (OVERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, there is still meaningful execution risk, with ongoing losses and heavy reliance on a small group of NGS customers, which could unsettle revenue and sentiment. Find out about the key risks to this Twist Bioscience narrative. Next Steps With sentiment clearly mixed, this is the moment to review the underlying data yourself and decide quickly how to shape your own view using 2 key rewards and 2 important warning signs Looking for more investment ideas? If you stop here, you risk missing other stocks that could suit your goals, so keep building your watchlist with focused, data driven ideas.  Target stronger long term value potential by scanning 47 high quality undervalued stocks that combine fundamentals with attractive pricing. Prioritise resilience in your portfolio by reviewing 62 resilient stocks with low risk scores that score well on stability and downside protection. Get ahead of the crowd by checking the screener containing 22 high quality undiscovered gems that still fly under most investors' radar.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n        and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n        financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n        Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n        Simply Wall St has no position in any stocks mentioned.Valuation is complex, but we're here to simplify it.Discover if Twist Bioscience might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2640894747","isCrawlerRequest":true}